Ignite Creation Date:
2025-12-25 @ 2:49 AM
Ignite Modification Date:
2025-12-30 @ 11:34 PM
Study NCT ID:
NCT00858533
Status:
COMPLETED
Last Update Posted:
2024-10-30
First Post:
2009-03-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Trial of Health At Work Workplace Health Intervention
Sponsor:
University of Liverpool
Organization:
Study Overview
Official Title:
A Pilot Controlled Feasibility Trial of Early Health At Work Workplace Intervention
Status:
COMPLETED
Status Verified Date:
2010-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
H@W
Brief Summary:
This pilot study will compare workplace health intervention delivered by advisors based in GP practices with normal GP care to assess the usefulness of the concept and its potential for wider use in a larger randomised controlled trial.
Detailed Description:
The aim of this pilot study is to examine the impact of H@W intervention(s) on job retention and return to work and compare outcomes with those from normal GP care. The target population for this study is people still at work but experiencing a work-related health problem as well as those off work. For the purpose of the study, short term sickness absence is defined as a period of 4 weeks or less and long term sickness absence defined as a period of 4 weeks or longer. Hypothesis
That H@W intervention in comparison to standard care:
* promotes work retention
* enables a quick and sustained return to work for those on short term sick leave (4 weeks or less)
* achieves sustained return to work for those on long term sick leave of 4 weeks or more. This could include a phased return to work.
* achieves positive outcomes which could mean leaving one job and starting another.
That H@W intervention in comparison to standard care:
* promotes work retention
* enables a quick and sustained return to work for those on short term sick leave (4 weeks or less)
* achieves sustained return to work for those on long term sick leave of 4 weeks or more. This could include a phased return to work.
* achieves positive outcomes which could mean leaving one job and starting another.
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: